To cath or not to cath? That used to be the question

American Heart Journal

Volumn 143, Issue 3, 2002, Pages 377-380

  Cannon, Christopher P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; LOW MOLECULAR WEIGHT HEPARIN; TIROFIBAN;

CLINICAL TRIAL; CONSERVATIVE TREATMENT; CORONARY STENT; DRUG COST; DRUG EFFICACY; EDITORIAL; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; PATIENT MONITORING; PRIORITY JOURNAL; ST SEGMENT; TREATMENT INDICATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0036191575     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.120971     Document Type: Article

References (15)

1. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial
2. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial: A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q-wave myocardial infarction
3. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative strategy
4. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy: Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial
5. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomized multicenter study
6. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban
7. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: The FRISC II invasive randomised trial
8. The TIMI risk score for unstable Angina/Non-ST elevation MI: A method for prognostication and therapeutic decision making
9. A randomized (double blind) study with the Sirolimus coated BX velocity balloon expandable stent [CYPHER) in the treatment of patients with de novo native coronary artery lesions
10. Diagnosing and managing unstable angina
11. ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Unstable Angina and Non-ST Segment Elevation Myocardial Infarction)
12. Invasive versus conservative management of unstable angina and non-Q-wave infarction: A metaanalysis
13. Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in schemic heart disease
14. Is there a benefit of early angiography in patients with ST segment depression myocardial infarction? An observational study
15. Management of acute coronary syndromes: Acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology